Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial

Press/Media: Press / Media

Period	2021 Jun 4

Media coverage

Title	Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
Media name/outlet	Respiratory Research
Country/Territory	United Kingdom
Date	21/6/4
URL	respiratory-research.biomedcentral.com/articles/10.1186/s12931-021-01766-0
Persons	Jungwon Park